---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-084689"
form_type: "8-K"
ticker: "OCGN"
cik: "0001372299"
company_name: "Ocugen, Inc."
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:43:15.277893+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ocugen prices $35M public offering of 30.4M shares at $1.15 per share

## Summary
- Gross proceeds of $35M; net proceeds expected ~$32.6M after underwriting discounts.
- Underwriter granted 30-day option to purchase up to 4,565,217 additional shares at same price.
- Proceeds to be used for general corporate purposes, working capital, and G&A expenses.
- Offering expected to close on or about August 2, 2024; Titan Partners Group sole book-runner.
- Financing led by a premier mutual fund with participation from leading life sciences investors.

## SEC filing metadata
- accession: 0001104659-24-084689
- form_type: 8-K
- ticker: OCGN
- cik: 0001372299
- company_name: Ocugen, Inc.
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372299/000110465924084689/0001104659-24-084689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372299/000110465924084689/tm2420013d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-084689
- JSON: https://secwatch.observer/filing/0001104659-24-084689.json
- Plain text: https://secwatch.observer/filing/0001104659-24-084689.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.